Panitumumab
Amgen,Takeda
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'panitumumab', 'pani ', 'nct04425239', 'icon,(-iconi)']
intermittent or continuous folfiri/pani for 1st line ras/braf wt mcrc: update of survival/toxicity &amp; preliminary results of ga from improve @ #wcgic2023 stop &amp; go seems feasible, less toxicity resistente mechanisms not yet resolved 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology